Prealbumin Levels as a Predictor of Subsequent Liver Metastases in Colorectal Cancer - Scorecard - MDSpire

Prealbumin Levels as a Predictor of Subsequent Liver Metastases in Colorectal Cancer

  • By

  • Han-bing Xie

  • Bei-bei Zhang

  • Lin Zhao

  • Le Liu

  • Ping-ping Liu

  • Xin Zhang

  • Shi-di Miao

  • Rui-tao Wang

  • Hai-tao Xu

  • November 25, 2025

  • 0 min

Share

Clinical Scorecard: Prealbumin Levels as a Predictor of Subsequent Liver Metastases in Colorectal Cancer

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with histopathologically confirmed CRC who underwent curative resection, meeting specific inclusion criteria.
Care Setting

Key Highlights

  • Add a highlight on the study's methodology.

Guideline-Based Recommendations

Diagnosis

    Management

    • A
    • d
    • j
    • u
    • v
    • a
    • n
    • t
    • c
    • h
    • e
    • m
    • o
    • t
    • h
    • e
    • r
    • a
    • p
    • y
    • b
    • a
    • s
    • e
    • d
    • o
    • n
    • N
    • C
    • C
    • N
    • /
    • E
    • S
    • M
    • O
    • g
    • u
    • i
    • d
    • e
    • l
    • i
    • n
    • e
    • s
    • (
    • s
    • p
    • e
    • c
    • i
    • f
    • y
    • s
    • o
    • u
    • r
    • c
    • e
    • )
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Adjuvant treatment includes FOLFOX, CAPEOX, or capecitabine, based on specific clinical criteria.

        Clinical Best Practices

        • Monitor prealbumin levels as part of nutritional assessment in CRC patients, ideally every 3 months post-surgery.

        References

        Original Source(s)

        Prealbumin Levels as a Predictor of Subsequent Liver Metastases in Colorectal Cancer

        • by Han-bing Xie, Bei-bei Zhang, Lin Zhao, Le Liu, Ping-ping Liu, Xin Zhang, Shi-di Miao, Rui-tao Wang, Hai-tao Xu

        • November 25, 2025

        Related Content

        Retraction: Construction and validation of nomogram model for endoscopic submucosal dissection in patients with early colorectal cancer based on intestinal microflora and clinical pathological parameters

        • May 4, 2026

        Combining Single-Cell and Spatial Transcriptomics Uncovers Glycolytic Diversity and NEK6-Driven Advancement in Colorectal Cancer

        Editorial: Insights into gastrointestinal cancer metastasis from preclinical models